44 Wealth Management’s Gilead Sciences GILD Stock Holding History

44 Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$276K	Sell	1,978 -956	-33%	-$134K	0.1%	168
2025 Q4	$360K	Buy	2,934 +12	+0.4%	+$1.46K	0.12%	160
2025 Q3	$324K	Sell	2,922 -1	-0%	-$114	0.11%	173
2025 Q2	$324K	Buy	2,923 +105	+4%	+$11.2K	0.11%	169
2025 Q1	$316K	Sell	2,818 -127	-4%	-$13.1K	0.12%	164
2024 Q4	$272K	Sell	2,945 -216	-7%	-$19.4K	0.1%	173
2024 Q3	$276K	Buy	+3,161	New	+$241K	0.1%	174
2023 Q2	$262K	Sell	3,395 -44	-1%	-$3.51K	0.09%	149
2023 Q1	$285K	Sell	3,439 -79	-2%	-$6.54K	0.1%	147
2022 Q4	$302K	Sell	3,518 -6	-0.2%	-$475	0.1%	144
2022 Q3	$217K	Sell	3,524 -527	-13%	-$33.2K	0.09%	156
2022 Q2	$250K	Sell	4,051 -811	-17%	-$50.2K	0.1%	147
2022 Q1	$289K	Buy	4,862 +839	+21%	+$53.6K	0.1%	145
2021 Q4	$292K	Buy	4,023 +873	+28%	+$60.1K	0.1%	149
2021 Q3	$220K	Sell	3,150 -163	-5%	-$11.5K	0.08%	159
2021 Q2	$228K	Buy	+3,313	New	+$221K	0.09%	161

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

44 Wealth Management's GILD Position: Q1 2026 in Review

44 Wealth Management reduced its Gilead Sciences (GILD) stake by 33% in Q1 2026, selling an estimated $134K and leaving 1,978 shares worth $276K. The position accounts for 0.1% of the portfolio, ranked #168.

44 Wealth Management first reported a position in GILD in Q2 2021 and has held it in 16 quarters since. The position peaked at $360K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

44 Wealth Management held 1,978 shares of Gilead Sciences worth $276K as of Q1 2026.
44 Wealth Management sold 956 Gilead Sciences shares in Q1 2026, an estimated $134K.
Gilead Sciences made up 0.1% of 44 Wealth Management's portfolio in Q1 2026, its #168 holding.
44 Wealth Management first reported a position in Gilead Sciences in Q2 2021 and has held it in 16 quarters since.
44 Wealth Management's Gilead Sciences position peaked at $360K in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on 44 Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.